Skip to Content

Join the 'Hepatitis C' group to help and get support from people like you.

Hepatitis C News

Related terms: Hepatitis C, Chronic, Chronic Hepatitis C, Hep C

Too Few Baby Boomers Get Hepatitis C Screening

Posted 29 Mar 2018 by Drugs.com

THURSDAY, March 29, 2018 – Despite recommendations, only about one in 10 U.S. baby boomers has been screened for hepatitis C virus (HCV), a new study reveals. Hepatitis C is a contagious virus that causes nearly half of the cases of liver cancer in the United States. Health officials estimate that about one in 30 Americans born between 1945 and 1965 (the baby boom generation) has chronic HCV ...

Surgeons Safely Transplant Kidneys From Donors With Hep C

Posted 6 Mar 2018 by Drugs.com

TUESDAY, March 6, 2018 – In what could be a breakthrough in the world of organ transplants, Johns Hopkins researchers have taken kidneys from people infected with hepatitis C and safely transplanted them without transmitting the disease. The surgeries gave new kidneys to 10 donor recipients – just a handful of the more than 420,000 Americans who currently struggle with potentially fatal ...

Lack of Awareness May Spur Spread of Hep C

Posted 1 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 1, 2017 – Only about half of people in the United States with hepatitis C know they have the curable disease, new data shows. That lack of awareness contributes to increasing rates of hepatitis C infection and means the country is unlikely to meet its own or World Health Organization target dates for eliminating the disease, researchers said. Hepatitis C can cause liver disease, ...

Tiny Opioid Victims: Addicted Moms-to-Be Transmit Hepatitis C

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – More fallout from the U.S. opioid epidemic: Wisconsin has seen a near doubling of women on Medicaid who have the hepatitis C virus (HCV) in pregnancy. In turn, this has fueled a rise in babies born with the dangerous infection. Widespread injection drug use has triggered rapid increases of hepatitis C infections among young adults nationwide, according to a new report ...

Hepatitis C Screening May Boost Opioid Treatment Success

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Opioid abuse therapy may be more effective if patients are screened for hepatitis C as part of the program, a new Canadian study says. The research found a sharp drop in opioid abuse among patients after they were told they tested positive for the hepatitis C virus (HCV). Hepatitis C causes liver disease that can lead to cirrhosis (scarring of the liver), liver cancer and ...

Semen Harbors Wide Range of Viruses

Posted 13 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 13, 2017 – Human semen provides a potential hiding place and breeding ground for a host of dangerous viruses, a new evidence review reports. The analysis of current medical literature revealed genetic evidence of 27 infectious viruses found in semen, including dread-inducing agents like Zika, Ebola, Marburg, Lassa fever and chikungunya, along with mumps, Epstein-Barr and chicken ...

Only About One-Third of Americans Use Condoms: CDC

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Condoms can help prevent pregnancy and the spread of sexually transmitted diseases (STDs), but only about a third of Americans use them, a new federal report shows. "The use of condoms is a public health issue," said report author Casey Copen, a statistician at the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics. "STDs can lead to ...

FDA Approves Expanded Labeling for Epclusa (sofosbuvir/velpatasvir) for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

Posted 9 Aug 2017 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 1, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Epclusa® (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include ...

Mavyret Approved for Hepatitis C

Posted 4 Aug 2017 by Drugs.com

FRIDAY, Aug. 4, 2017 --Mavyret (glecaprevir and pibrentasvir) has been approved by the U.S. Food and Drug Administration to treat adults with certain types of chronic hepatitis C virus (HCV). The combination drug is the first approved therapy for hepatitis C to require as few as eight weeks of treatment, the FDA said in a news release. Other therapies require treatment of 12 weeks or longer. ...

FDA Approves Mavyret (glecaprevir and pibrentasvir) for Hepatitis C

Posted 3 Aug 2017 by Drugs.com

August 3, 2017 – The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection ...

FDA Approves Vosevi (sofosbuvir/velpatasvir/voxilaprevir) for Re-Treatment of Adults with Chronic Hepatitis C Virus

Posted 18 Jul 2017 by Drugs.com

July 18, 2017 – The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir – and a new drug, voxilaprevir. Vosevi is the first treatment approved for patients w ...

Surf's Up! How to Plan for a Safe Beach Vacation

Posted 25 Jun 2017 by Drugs.com

SATURDAY, June 24, 2017 – Heading to the beach this summer? Make safety part of your vacation planning. Sun protection belongs at the top of your packing list. Must-haves include sunscreen, sunglasses, protective clothing and a hat, the U.S. Food and Drug Administration says. Here are some of the agency's other recommendations: Don't use tanning beds to pre-tan before a beach vacation. The lamps ...

U.S. Liver Cancer Deaths Have Doubled Since 1980s: Study

Posted 7 Jun 2017 by Drugs.com

WEDNESDAY, June 7, 2017 – Liver cancer is the fastest-growing cause of cancer deaths in the United States, a new study reports. Liver cancer cases have been on the rise since the mid-1970s, a trend expected to continue through at least 2030. Death rates from the disease have doubled since the mid-1980s – the fastest increase of any cancer, according to the American Cancer Society, which ...

New Combo Pill Offers Hope to Hepatitis C Patients Who Fail Other Treatment

Posted 1 Jun 2017 by Drugs.com

WEDNESDAY, May 31, 2017 – A pill that contains three powerful antiviral drugs might offer a cure for many hepatitis C patients who have failed other treatments, researchers report. The pill – which contains the antiviral drugs sofosbuvir (Sovaldi), velpatasvir and voxilaprevir – was nearly 100 percent effective in curing hepatitis C in patients whose disease returned after treatment with other ...

New Hepatitis C Infections Hit 15-Year High: CDC

Posted 14 May 2017 by Drugs.com

FRIDAY, May 12, 2017 – Reports of new hepatitis C infections in the United States nearly tripled over five years, reaching a 15-year high, federal government data show. The highest number of new infections were reported among 20- to 29-year-olds. Many stemmed from the growing use of injected drugs linked to the current opioid epidemic, officials said. The number of reported cases rose from 850 ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Infectious Hepatitis

Related Drug Support Groups

Harvoni, Sovaldi, Epclusa, ribavirin, Incivek, Zepatier, Pegasys, sofosbuvir, Victrelis, view more... Mavyret, PegIntron, Daklinza, Copegus, telaprevir, interferon alfa-2b, Viekira Pak, Ribasphere, Rebetol, interferon alfa-2b / ribavirin, boceprevir, ledipasvir / sofosbuvir, Vosevi, sofosbuvir / velpatasvir, daclatasvir, RibaPak, Intron A, Rebetron, simeprevir, Viekira XR, peginterferon alfa-2a, Technivie, peginterferon alfa-2b, interferon alfa-2a, Olysio, Roferon-A, ombitasvir / paritaprevir / ritonavir, dasabuvir / ombitasvir / paritaprevir / ritonavir, RibaTab, Moderiba, interferon alfacon-1, elbasvir / grazoprevir, sofosbuvir / velpatasvir / voxilaprevir, Infergen, glecaprevir / pibrentasvir